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The filamentous fungus Scedosporium aurantiacum and the bacterium Pseudomonas
aeruginosa are opportunistic pathogens isolated from lungs of the cystic fibrosis (CF)
patients. P. aeruginosa has been known to suppress the growth of a number of
CF related fungi such as Aspergillus fumigatus, Candida albicans, and Cryptococcus
neoformans. However, the interactions between P. aeruginosa and S. aurantiacum have
not been investigated in depth. Hence we assessed the effect of P. aeruginosa reference
strain PAO1 and two clinical isolates PASS1 and PASS2 on the growth of two clinical S.
aurantiacum isolates WM 06.482 and WM 08.202 using solid plate assays and liquid
cultures, in a synthetic medium mimicking the nutrient condition in the CF sputum.
Solid plate assays showed a clear inhibition of growth of both S. aurantiacum strains
when cultured with P. aeruginosa strains PASS1 and PAO1. The inhibitory effect was
confirmed by confocal microscopy. In addition to using chemical fluorescent stains,
strains tagged with yfp (P. aeruginosa PASS1) and mCherry (S. aurantiacumWM06.482)
were created to facilitate detailed microscopic observations on strain interaction. To
our knowledge, this is the first study describing successful genetic transformation of S.
aurantiacum. Inhibition of growth was observed only in co-cultures of P. aeruginosa and
S. aurantiacum; the cell fractions obtained from independent bacterial monocultures
failed to initiate a response against the fungus. In the liquid co-cultures, biofilm forming
P. aeruginosa strains PASS1 and PAO1 displayed higher inhibition of fungal growth
when compared to PASS2. No change was observed in the inhibition pattern when
direct cell contact between the bacterial and fungal strains was prevented using a
separation membrane suggesting the involvement of extracellular metabolites in the
fungal inhibition. However, one of the most commonly described bacterial virulence
factors, pyocyanin, had no effect against either of the S. aurantiacum strains. This study
shows that P. aeruginosa has a substantial inhibitory effect on the growth of the recently
described CF fungal pathogen S. aurantiacum. The findings also highlighted that P.
aeruginosa biofilm formation is important but not crucial for inhibiting the growth of S.
aurantiacum in a lung- mimicking environment.
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Introduction
Cystic ﬁbrosis (CF) is one of the most common, potentially
lethal, genetically inherited disorders aﬀecting mainly the
European Caucasian population (O’Sullivan and Freedman,
2009). Although the disease aﬀects a number of organs and
systems in the human body, lungs remain the main site of
infection in CF patients (Quinton, 1999). The inherited condition
stems from the mutation of the CF transmembrane conductance
regulator (CFTR) gene, which regulates the transport of chloride
ions across the plasma membrane of the epithelial cells (Boucher,
2007). Impaired ion exchange reduces the mucociliary clearance,
which leads to accumulation of hyper-viscous mucus in the
airway surfaces, thus providing ideal conditions for the growth
of microorganisms (Delhaes et al., 2012). Various molecular and
microbiology based approaches have revealed the polymicrobial
nature of the infections in CF with the identiﬁcation of complex
microbiota including bacteria, fungi, and viruses (Lynch and
Bruce, 2013). Most of these microorganisms are either acquired
from the environment or through contact with other infected
patients (Lipuma, 2010).
Bacteria constitute the major portion of the microorganisms
associated with CF. The most common bacterial inhabitants of
the CF airways include Haemophilus influenzae, Staphylococcus
aureus, Pseudomonas Aeruginosa, and Burkholderia cepacia
complex (BCC) (Harrison, 2007; Lipuma, 2010). Among them,
P. aeruginosa is the most dominant bacterial species known
to cause chronic respiratory infections in more than 50% of
adult CF patients (Coutinho et al., 2008). P. aeruginosa is a
ubiquitous Gram-negative bacterium possessing a wide variety of
pathogenicity factors to evade the host defense system (Davies,
2002). During the early stages of infection, the bacterium
attaches itself to lung epithelial cell surface receptors through
speciﬁc adhesins and secretes extracellular products to prolong
its survival in the CF airways (Tang et al., 1995). The extracellular
products secreted by P. aeruginosa include enzymes such as
elastase and alkaline protease, exotoxins, siderophores, and
phenazines such as pyocyanin with a known role in virulence
(Haas et al., 1991). Moreover, P. aeruginosa cells form bioﬁlms in
order to proliferate inside the lungs and protect themselves from
antibiotic agents (Singh et al., 2000).
In addition to bacteria, some fungal species are also known to
colonize the respiratory tracts of CF patients (Cimon et al., 2000;
Pihet et al., 2009). Mycological examination of the specimens
obtained from CF patients have shown that Aspergillus fumigatus
is the most predominant fungal colonizer of the CF lungs as
it has been recovered from 6 to 71% of CF patients (Bakare
et al., 2003; Horre et al., 2010). However, the presence of non-
Aspergillus fungal species often remains unnoticed owing to
the lack of sensitive culture techniques to examine the sputum
specimens from CF patients (Delhaes et al., 2012). Recently,
a more targeted approach has been developed by combining
molecular techniques with laboratory culture methods, which
can now identify a wide range of fungal pathogens in the
expectorated sputa (Middleton et al., 2013). Studies conducted
on CF patients in Australia and certain parts of Europe have
conﬁrmed the emergence of a new fungal genus Scedosporium
(originally called Pseudallescheria) that causes infections in the
lungs of immunocompromised hosts (Blyth et al., 2010a; Paugam
et al., 2010; Lackner et al., 2014). Scedosporium sp. have been
isolated from the sputum specimens of 14.7–17.4% of Australian
CF patients which makes it the second most common fungal
respiratory pathogen associated with CF (Blyth et al., 2010a,b).
Scedosporium aurantiacum is a recently identiﬁed, highly virulent
member of the Scedosporium sp. complex recovered from one
in six CF patients in Sydney (Heath et al., 2009; Blyth et al.,
2010b; Harun et al., 2010). The clinical consequences of the
S. aurantiacum colonization or infections in the CF patients
remain to be explored (Harun et al., 2010).
According to the clinical reports, the prevalence of fungi in
the respiratory tracts of CF patients is mainly aﬀected by the
bacteria present, and the interactions between the bacteria and
fungi potentially impact the disease outcome (Sibley et al., 2006;
Chotirmall et al., 2010; Leclair and Hogan, 2010). Several in
vitro studies have reported an inhibitory eﬀect of P. aeruginosa
against the common lung co-inhabitants such as A. fumigatus
or the yeasts Candida albicans, and Cryptococcus neoformans
(Hogan and Kolter, 2002; Bandara et al., 2010; Cugini et al.,
2010). Similar data for S. aurantiacum are lacking. Reﬂecting the
increasing importance of S. aurantiacum in CF, we examined
the eﬀect of clinical P. aeruginosa CF isolates PASS1 and PASS2
and laboratory reference strain PAO1 on the growth of two
clinical S. aurantiacum isolatesWM06.482 andWM08.202 using
solid plate assays and liquid co-cultures containing medium that
mimics the nutritional content of human CF sputum (Palmer
et al., 2007).
Materials and Methods
Growth and Maintenance of Strains
Strains used in the study are listed in Table 1. P. aeruginosa
PASS1 and PASS2 were isolated from the sputum samples
of CF patients (Penesyan et al., under review). A common
laboratory ‘reference’ strain PAO1 (Lewenza et al., 2014) was
also included in the study. S. aurantiacum strains WM 06.482
and WM 08.202 were obtained from the culture collection of
theMedicalMycology Research Laboratory, Centre for Infectious
Diseases and Microbiology, Westmead Hospital, Sydney, NSW,
Australia (Kaur et al., 2015). Virulence levels of all P. aeruginosa
strains used in this study have been tested previously using
Caenorhabditis elegans based infection model (Lewenza et al.,
2014; Penesyan et al., under review). Virulence studies of
S. aurantiacum have been performed using Galleria mellonella
larvae model (Kaur et al., 2015).
Pseudomonas aeruginosa strains were revived from frozen
stocks stored at−80◦C by streaking on LB (Luria Bertani, Sigma)
plates and incubation overnight at 37◦C. Bacterial colonies
were inoculated into LB broth and incubated at 37◦C on an
orbital shaker (200 rpm) overnight. Following fractions were
prepared from overnight cultures of the P. aeruginosa strains:
(1) Heat killed cells were obtained by incubating 1 ml of an
overnight cell culture at 80◦C for 60 min. Absence of any
viable cells was conﬁrmed by plating on LB agar medium; (2)
Frontiers in Microbiology | www.frontiersin.org 2 August 2015 | Volume 6 | Article 866
Kaur et al. Impact of P. aeruginosa on S. aurantiacum
TABLE 1 | Pseudomonas aeruginosa and Scedosporium aurantiacum strains used in the study.
Strain Strain name Source Virulence level Reference
PASS1 P. aeruginosa Sputum sample of a cystic fibrosis (CF) patient Sydney, NSW, Australia High Penesyan et al. (under review)
PASS2 P. aeruginosa Sputum sample of a CF patient Sydney, NSW, Australia Low Penesyan et al. (under review)
PAO1 (ATCC P. aeruginosa Wound exudate High Holloway (1955)
15692) Melbourne, VIC, Australia
WM 06.482 S. aurantiacum Invasive clinical isolate from CF patient Sydney, NSW, Australia High Kaur et al. (2015)
WM 08.202 S. aurantiacum Type strain from a wound exudate Santiago de Compostela (Spain) Low Kaur et al. (2015)
Cell lysates were obtained after sonicating the cells (50 ml)
on ice for 10 min in an ultrasonic processor followed by
collection of the supernatant after centrifugation at 10,000 × g
for 30 min; (3) Cell culture supernatants were collected by
centrifuging 50 ml of overnight cultures of P. aeruginosa strains
at 10,000 × g for 30 min. Supernatants were then freeze dried
and resuspended in 100 μl of 1x PBS and stored at 4◦C until
use.
Fungal strains were maintained on PDA (potato dextrose agar,
BD, DifcoTM) plates at 37◦C. After 5 days of growth, the conidia
were scraped into sterile saline solution (0.9% w/v NaCl and
0.01% v/v Tween 80) and the suspension was ﬁltered through
a sterile cotton wool to separate the conidia from the hyphal
debris. Conidia were washed with 1x PBS to remove traces of
saline and the inoculum was adjusted to a McFarland standard
concentration of 2.5 × 105 conidia/ml. Concentration of conidia
was conﬁrmed using Neubauer counting chamber and additional
plate counting.
Construction of Strains Tagged with
Fluorescent Proteins
Pseudomonas aeruginosa Strain Expressing Yellow
Fluorescent Protein (YFP)
Plasmid pUCPyfp (Gloag et al., 2013) encoding yellow ﬂuorescent
protein (YFP) was used to transform the P. aeruginosa PASS1
strain. In order to make electrocompetent cells, PASS1 was
cultured in 5 ml of LB broth overnight at 42◦C and 200 rpm.
Cells were harvested by centrifugation (14,000 g for 15 min at
4◦C) and the ionic strength of the suspension was reduced by
rigorous washing with 1x M9 minimal salts medium (Sigma)
followed by two washes with ice-cold sterile milliQ water.
Bacterial cells were transformed by electroporation as described
by Dower et al. (1988) by adding 1 μg of the plasmid DNA
to 20 μl of the washed cell aliquots. At the end of the
procedure, cells were streaked on LB plates containing 8 mg/ml
ampicillin and incubated for up to 48 h at 37◦C to select for the
transformants.
Construction of the S. aurantiacum Strain Expressing
mCherry
The mCherry gene was PCR ampliﬁed from the pmcherry-c1
vector (Clontech Laboratories, USA) using mCherry.fwd and
mCherry.rev primers (Table 2) and was expressed under
the Trichoderma reesei pyruvate kinase (pki) promoter,
which was ampliﬁed from the pCBH1corlin vector (Te’o
et al., 2000) using pki.fwd and pki.rev primers. In addition,
TABLE 2 | Sequence of primers used for the construction of
transformation cassettes.
Primer name Sequence (5′–3′)
mCherry. fwd GAA GAACCT CTT AAC CTC TAG (pki sequence) ATG
GTG AGC AAG GGC GAG G
mCherry. rev CAT GCG GGT ACC (KpnI) CTA TTA CTT GTA CAG CTC
GTC CAT GC
pki. fwd TGC TGC GAT ATC (EcoRV) CTT AAG TTA G TA ACT
AGT GGA TC
pki.rev CTC GCC CTT GCT CAC CAT (mCherry sequence)
CTA GAG GTT AAG AGG TTC TTC
pki-hph. fwd TAC GCG GCG CGC C CT TAA G (AflII) TT AG T AAC
TAG TGG ATC
pki-hph.rev CAT GCT AAG CTT (HindIII) CTA TTC CTT TGC
CCG CGG AC
The primers contain engineered restriction sites shown in shading and the
overlapping sequences are shown in bold.
a DNA fragment featuring the pki promoter together
with the hygromycin B resistance gene (pki-hph) was
PCR ampliﬁed using primer pkihph.fwd and pki-hph.rev
to allow selection of transformants. The fragments
were engineered to contain restriction sites as needed
(Table 2).
The primers pki.fwd and mCherry.rev were used to fuse
the separately ampliﬁed pki and mCherry fragments in an
overlap extension PCR as described by Thornton (2015).
The fragment pki-hph was digested with restriction enzymes
HindIII and AflII (Fermentas, Thermo Scientiﬁc, USA) and
fragment pki-mcherry was digested with EcoRV and KpnI.
The digested products pki-hph and pkimcherry were gel
puriﬁed using QIAquick gel extraction kit (Qiagen, USA)
and inserted into MCS-1 (multiple cloning site) and MCS-
2 of the pETDuet-1 plasmid, respectively (Supplementary
Figure S1). Finally, the puriﬁed vectors and inserts were
ligated using T4 ligase (Fermentas, USA) at a 1:3 molar
ratio for 2 h at room temperature. The ﬁnal ligated vector
(pETDuet-phpm) was introduced into Escherichia coli DH5α
competent cells as described by Inoue et al. (1990). Selection
of transformants was performed on LB agar plates containing
ampicillin (100 μg/ml) and incubating at 37◦C. Selected
transformants were grown in 3 ml of LB and plasmid DNA
was isolated using QIAprep Spin Miniprep kit (Qiagen, USA).
The plasmid pETDuet-phpm was sequenced by AGRF, Sydney,
NSW, USA to check sequence alignment of the inserted gene
cassettes.
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The pETDuet-phpm DNA was introduced into highly
virulent S. aurantiacum WM 06.482 using protoplast-mediated
transformation based on the method adopted from Penttilä et al.
(1987) with modiﬁcations. The young hyphae obtained from an
overnight culture of WM 06.482 on PDA plates with cellophane
at 28◦C were digested with 10 mg/ml of lysing enzyme from
T. harzianum (Sigma–Aldrich, Australia) to obtain protoplasts
which were then ﬁltered through a sterile sintered glass ﬁlter
(porosity 1). Osmotically stabilized protoplasts were transformed
with 5 μg of plasmid DNA as described by Penttilä et al. (1987).
Transformed protoplasts were mixed with 10 ml of molten
agar (1.5% w/v KH2PO4, 0.5% w/v NH4SO4, 2% w/v glucose,
1 M sorbitol, pH 5.5) containing hygromycin B (410 U/ml)
and overlayed onto PDA plates which were incubated at 28◦C
for 3–5 days. Hygromycin resistant colonies were restreaked
onto fresh PDA plates containing hygromycin B (410 U/ml)
for a second round of selection. Transformation eﬃciency was
calculated as number of transformants per μg of plasmid DNA.
Expression of the mCherry protein in selected transformants was
conﬁrmed using Fluoview FV1000 inverted confocal microscope
(Olympus) with an excitation and emission wavelength 488/633
nm (HeNe).
Growth Inhibition Assays
The eﬀect of P. aeruginosa on the growth of S. aurantiacum
was tested in diﬀerent combinations on both solid and liquid
growth media. Combinations of bacterial and fungal strains for
the testing are presented in Table 3.
Cross Streak Assay using Live Cells
The eﬀect of bacteria on fungal growth was assessed using an agar
plate method described by Kerr (1999), with slight modiﬁcations
adopted from Chen et al. (2013). P. aeruginosa strains PASS1,
PASS2, and PAO1; and S. aurantiacum strains WM 06.482
and WM 08.202, were cultured together on a synthetic cystic
ﬁbrosis medium (SCFM) that mimics the nutritional content of
human CF sputum. SCFM contains average concentrations of
ions, free amino acids, glucose, and lactate present in the CF
sputum samples (Palmer et al., 2007). Solid SCFM agar plates
were made with an addition of 2% w/v agar to liquid SCFM
medium. A sterile cotton swab was used to draw a straight vertical
line of P. aeruginosa cells (1 × 108 CFU/ml=0.5 McFarland
standard concentration) across the plate. At the same time,
S. aurantiacum conidia (2.5 × 105 conidia/ml = 0.5 McFarland
standard concentration) were inoculated with a cotton swab
horizontally across the upper part of the plate preventing any
direct contact between fungi and bacteria. The plates were dried
at room temperature for 15 min and incubated at 37◦C. Digital
photography was performed after 24 h to visualize the growth of
both bacterial and the fungal strains tested on the plate.
Disk Inhibition Method using Live Cells and Cell
Fractions
Sterile ﬁlter paper disks (Whatman no. 1; Sigma–Aldrich), 7 mm
in diameter, were impregnated with 20 μl of the P. aeruginosa
PASS1, PASS2, and PAO1 cell fractions, i.e., cell lysates, cell
culture supernatant and heat inactivated cells (see preparation in
section 1.1) and placed on an SCFM plate that was freshly surface
seeded with 100 μl (2.5 × 105 conidia/ml) of S. aurantiacum
conidia (WM 06.482 or WM 08.202). A suspension of live
P. aeruginosa cells was included for comparison. The plates were
incubated at 37◦C for up to 3 days and observed at regular
intervals for the appearance of any clear inhibition zones around
the disks. Assays were repeated in three biological replicates.
A relative inhibition index was calculated for each P. aeruginosa
isolate by dividing the area of activity (diﬀerence between the area
of the inhibition zone and area of the colony) by the area of the
colony.
Effect of Bacteria on the Fungal Growth in Liquid
Co-cultures
Interactions between P. aeruginosa and S. aurantiacum were
observed in liquidmedium using both chemical ﬂuorescent stains
and genetically labeled strains of bacteria and fungi in a direct
contact with each other. In case of ﬂuorescently labeled co-
cultures, 1 × 108 CFU/ml of P. aeruginosa PASS1, PASS2, and
PAO1 and 2.5 × 105 conidia/ml of S. aurantiacum WM 06.482
and WM 08.202 were inoculated in 20 ml SCFM medium in
100 ml shake ﬂasks and incubated for 24 h at 37◦C on an
orbital shaker at 150 rpm. Aliquots were taken on a sterile
glass slide from the co-cultures after every 4 h, washed with 1x
PBS and ﬁxed using 2% v/v paraformaldehyde (Sigma–Aldrich).
The co-cultures were stained with DNA speciﬁc Syto9 (0.6 μM)
and mitochondria speciﬁc Mito-TrackerR Red FM (25 nM) for
15 min in the dark as per the manufacturer’s protocol (Molecular
Probes, Life Technologies). Bacterial cells were expected to stain
with Syto9 whereas fungal cells would stain with Mito-TrackerR
Red FM. Fixed specimens were imaged using Fluoview FV1000
inverted confocal microscope (Olympus) with an excitation and
emission wavelength of 488 nm (Ar) and 633 nm (HeNe).
The genetically tagged P. aeruginosa PASS1yfp strain and
S. aurantiacum WM 06.482mCherry strain were also cultured
together in 20 ml of SCFM for 24 h at 37◦C, shaking at 150 rpm.
At the end of the incubation period, cells were washed and
ﬁxed on sterile glass slides as above. Imaging was performed
with a confocal microscope using an excitation and emission
TABLE 3 | Types of cultures used to investigate the effect of different P. aeruginosa strains on S. aurantiacum.
Type of co-culture P. aeruginosa strains S. aurantiacum strains
Solid plate (cross streak, disk inhibition assay) PASS1, PASS2, PAO1 WM 06.482, WM 08.202
Liquid cultures (chemical fluorescent dyes) PASS1, PASS2, PAO1(stained with Syto9) WM 06.482, WM 08.202 (stained with Mito tracker FR)
Liquid culture (genetically tagged strains) PASS1 (yfp-labeled) WM 06.482 (mCherry-labeled)
Liquid culture (addition of an antibiotic) PASS1 (yfp-labeled) WM 06.482 (mCherry-labeled)
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wavelength of 488 nm (blue laser diode for yfp) and 561 nm
(yellow–green laser for mCherry) respectively. Liquid co-cultures
with genetically labeled PASS1 and WM 06.482 strains were
also repeated by adding diﬀerent concentrations of gentamicin
(2.5–10 mg/ml), which is a commonly used antibiotic against
bacteria (Doring et al., 2000; Lin et al., 2011). Image analysis for
both types of co-cultures was performed using IMARIS imaging
software.
Transwell Assay with Polycarbonate Membranes
In order to explore the role of secreted bacterial metabolites
on the fungi, P. aeruginosa strains PASS1, PASS2, and PAO1
and S. aurantiacum strains WM 06.482 and WM 08.202
were co-cultured in SCFM in sterile six-well Transwell plates
(Corning) with polycarbonate cell culture inserts (0.4 μm,
Sigma–Aldrich) in order to prevent direct contact between the
fungal and bacterial strains. P. aeruginosa (1 × 108 CFU/ml) and
S. aurantiacum (2.5 × 105 conidia/ml) were inoculated in the
bottom and top of the membrane insert, respectively. The plates
were incubated at 37◦C for 24 h and any inhibition of the growth
of S. aurantiacum was measured as a diﬀerence in the dry weight
of the S. aurantiacum cultured with or without P. aeruginosa. The
method of calculating dry weight was adopted from Kaur et al.
(2015).
Effect of Phenazines
Phenazines were extracted from all P. aeruginosa strains (PASS1,
PASS2, and PAO1) cultured in 5 ml of LB (in three biological
replicates) for 2 days at 37◦C using chloroform according to a
method described by Mavrodi et al. (2001). Crude phenazine
extracts were dried under reduced pressure to remove the
solvent, resuspended in 80% acetonitrile (ACN) and applied to
the ﬁlter paper disks (Whatman paper no. 1). The presence of
pyocyanin in the crude phenazine extracts was conﬁrmed using
Ultra High Performance Liquid Chromatography (UHPLC) as
described by Penesyan et al. (under review). While the absolute
concentration of pyocyanin in the crude phenazine extracts
from the three P. aeruginosa strains was not known, major
experimental discrepancy was minimized by using same amount
(20 μl) of crude extracts for the testing. The eﬀect of these
crude extracts on the fungal growth was determined using a disk
inhibition assay (as described in section Disk Inhibition Method
using Live Cells and Cell Fractions) where disks containing
20 μl of phenazine extracts from diﬀerent P. aeruginosa isolates
were air-dried and placed on SCFM agar plates freshly spread
with 2.5 × 105 conidia/ml of S. aurantiacum strains (WM
06.482 and WM 08.202). The activity of blank 80% ACN, blank
LB medium extract and the solution of commercial pyocyanin
(10 mM, Sigma–Aldrich) were also tested against S. aurantiacum
for comparison. Plates were incubated for 48 h at 37◦C and
observed for the presence of clearing zones around the ﬁlter paper
disks as an indication of inhibitory activity of the extracts on
fungal growth.
Statistical Analysis
Statistical signiﬁcance between the means of diﬀerent
experimental datasets was analyzed using two-tailed Student’s
t-test. SD with p-value less than 0.05 was considered signiﬁcant.
All experiments were performed in biological triplicates.
Results
Inhibition of S. aurantiacum Growth by Live
P. aeruginosa Cells
When S. aurantiacum strains WM 06.482 (high virulence) and
WM 08.202 (low virulence) were cross streaked against three
diﬀerent P. aeruginosa isolates PAO1, PASS1, and PASS2 on
the SCFM agar medium, an area of inhibition was observed
in the growth of both S. aurantiacum strains after 24 h
(Figures 1A–F). It was evident from the size of the inhibition area
that the bacterial strains had lesser impact on the highly virulent
S. aurantiacum strain WM 06.482 (Figures 1A,B) compared
to the less virulent WM 08.202 strain (Figures 1D,E). Out of
the three bacterial strains studied, P. aeruginosa PASS2 had the
weakest inhibitory eﬀect on the S. aurantiacum strains in the plate
test as seen in Figures 1C,F.
Effect of P. aeruginosa Cell Extracts on
S. aurantiacum
The eﬀect of diﬀerent cell fractions, i.e., the culture supernatant
and cell lysate, and heat inactivated cells of P. aeruginosa strains
PASS1, PASS2, and PAO1 was further tested on the growth of
S. aurantiacum WM 06.482 and WM 08.202 using the disk
inhibition method. Following 48 h incubation, clear inhibition
zones were observed on plates inoculated with living cells of
P. aeruginosa PASS1 and the reference strain PAO1 and their
respective cell lysates. The inhibitory eﬀect of P. aeruginosa was
expressed as a relative inhibition index (Figure 2).
Living cells of both PAO1 and PASS1 and their corresponding
cell lysates displayed a higher inhibitory activity against the
less virulent S. aurantiacum strain WM 08.202 compared to
the high virulence strain WM 06.482. Cell supernatants and
heat killed P. aeruginosa cells failed to elicit a response against
either of the fungal strains. In a separate experiment, the eﬀect
of S. aurantiacum was also tested against P. aeruginosa by
incubating ﬁlter disks impregnated with S. aurantiacum conidia
and cell fractions on the plates freshly seeded with P. aeruginosa
cells. As S. aurantiacum failed to display any inhibition against
P. aeruginosa, these interactions were not studied further (data
not shown).
Effect of P. aeruginosa on Fungal Physiology
Pseudomonas–Scedosporium interactions were also studied using
confocal microscopy by imaging cellular aggregates from liquid
co-cultures labeled with ﬂuorescent stains. Confocal images
demonstrated an inhibitory eﬀect of the P. aeruginosa PASS1
(isolated from sputum of a CF patient) and the reference strain
PAO1 on the growth and development of both S. aurantiacum
strains tested (Figures 3A–F). In the course of 24 h, the bacteria
had attached to the surface of fungal hyphae and formed bioﬁlm-
like structures containing a high density of bacterial cells but
very few fungal hyphae. The tested bacterial strains had a
weaker impact on the more virulent WM 06.482 compared
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FIGURE 1 | Cross-streak plate assay between different strains of
Pseudomonas aeruginosa and Scedosporium aurantiacum on synthetic
cystic fibrosis medium (SCFM) agar plates. All bacterial strains were
inoculated vertically whereas the fungal strains were streaked horizontally across
the upper part of the SCFM agar plate. The plates were incubated at 37◦C for
24–48 h. (A–C) Inhibition of S. aurantiacum strain WM 06.482 by PAO1, PASS1,
and PASS2 strains of P. aeruginosa. (D–F) Inhibition of S. aurantiacum strain
WM 08.202 by PAO1, PASS1, and PASS2 strains of P. aeruginosa.
FIGURE 2 | Susceptibility of S. aurantiacum (WM 06.482 and WM 08.202) to P. aeruginosa (PAO1, PASS1, and PASS2) and their cell lysate fractions.
Relative inhibition index was calculated as the average value of three replicates (n = 3) with a p-value <0.05 considered as significant.
to the less virulent WM 08.202, showing the resistant nature
of the more virulent strain also highlighted in the plate tests.
Although diﬀerent ﬂuorescent stains were used to distinguish
between P. aeruginosa and S. aurantiacum in liquid cultures, it
was diﬃcult to visualize the detailed eﬀect of bacteria on the
fungal hyphae due to permeabilisation of the Syto9 dye by both
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FIGURE 3 | Confocal laser scanning microscope (CLSM) images of
interactions between P. aeruginosa (PAO1, PASS1, and PASS2) and
S. aurantiacum (WM 06.482 and WM 08.202) as observed after
co-incubating both the organisms in SCFM liquid medium at 37◦C for
24 h. P. aeruginosa cells are stained with Syto9 (shown in green) and
S. aurantiacum with Mito-tracker deep red FM (shown in blue). 3D
re-construction of CLSM datasets was performed using IMARIS software
package (Bitplane). Scale bar = 50 μm. (A–C) CLSM images of co-culture of
WM 06.482 with PAO1, PASS1, and PASS2, respectively. (D–F) CLSM images
of co-culture of WM 08.202 with PAO1, PASS1, and PASS2, respectively.
P. aeruginosa and S. aurantiacum. No growth inhibiting eﬀect
was observed when the fungal strains were co-cultured with
PASS2 as indicated by dense growth of fungi in Figures 3C,F.
These observations were also consistent with the results seen in
the assays carried on plates.
Interactions between Genetically Tagged
P. aeruginosa and S. aurantiacum Strains
To circumvent the diﬃculty in diﬀerentiating between bacteria
and fungi in liquid co-cultures, genetically tagged P. aeruginosa
strain PASS1 expressing yfp and S. aurantiacum strain
WM 06.482 expressing mCherry were developed. With this
arrangement, it was observed that the bacteria started colonizing
the fungal conidia soon after incubating them together in
the SCFM (Figure 4A). Thus, within 8 h, bacteria began
aligning themselves along the length of fungal hyphae as seen in
Figures 4B,C. After 24 h, large clumps of P. aeruginosa cells were
observed on S. aurantiacum hyphal ﬁlaments (Figure 4D), and
the amount of hyphae was also reduced in number compared to
the S. aurantiacum control without the bacteria (Figure 4E).
Effect of Antibiotics used in Clinical Practice
on Co-cultures
Analysis of the plate cultures and confocal images conﬁrmed
that P. aeruginosa had an inhibitory eﬀect on the growth of
S. aurantiacum. Therefore, in order to further validate this
ﬁnding and to reveal the possible eﬀect of antibiotic therapy on
S. aurantiacum and P. aeruginosa mixed populations present in
CF lungs, co-culturing was repeated with an addition of varying
amounts of gentamicin (2.5–10 mg/ml) to selectively inhibit
the growth of P. aeruginosa. S. aurantiacum-P. aeruginosa co-
cultures were also maintained without the addition of gentamicin
for comparison (Figure 5A). All bacteria were killed at a
concentration of 8 mg/ml of gentamicin. As seen from Figure 5B,
S. aurantiacum strain WM 06.482 was growing actively in the
absence of P. aeruginosa strain PASS1 indicating the reversal
of the inhibitory eﬀect caused by live bacteria against the
fungus.
Indirect (non-physical) Interactions between
P. aeruginosa and S. aurantiacum
To investigate whether physical contact between P. aeruginosa
and S. aurantiacum was important to trigger growth inhibition,
co-cultures were performed in six-well plates ﬁtted with
polycarbonate membranes to prevent direct contact between
P. aeruginosa and S. aurantiacum cells while allowing free
exchange of nutrients and extracellular molecules between the
organisms. Growth of the less virulent S. aurantiacum strain
WM 08.202 was inhibited when co-cultured with PAO1 and
PASS1, evident from the substantial decrease in the fungal
biomass (Figure 6) when compared to the culture of WM 08.202
maintained for the same amount of time.
Pseudomonas aeruginosa isolate PASS1 and the reference
strain PAO1 showed a milder inhibitory eﬀect against the
high virulence S. aurantiacum strain WM 06.482. The PASS2
strain had little or almost no eﬀect on growth of either of
the S. aurantiacum strains. The results suggested that cell–cell
contact was in fact not necessary to bring about inhibition of the
growth of S. aurantiacum by P. aeruginosa and that the inhibition
might involve bacterial metabolites and/or extracellular signaling
molecules. In addition, S. aurantiacum strains WM 06.482 and
WM 08.202 produced a red colored pigment when co-cultured
with clinical P. aeruginosa strain PASS1 and reference strain
PAO1. No such pigment was observed in the co-cultures
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FIGURE 4 | Adhesion and colonization of mCherry-tagged
S. aurantiacum strain WM 06.482 (shown in red) by P. aeruginosa strain
PASS1 tagged with yfp (shown in green) during coculturing in SCFM for
24 h at 37◦C. Scale bar = 20 μm. (A) P. aeruginosa cells adhered to
germinating S. aurantiacum conidia after 2 h of incubation as viewed by DIC.
(B,C) after 8 h, some young hyphae were surrounded by bacterial cells.
(D) Bacteria can be seen attached to the hyphal filaments after incubation for
24 h. (E) Healthy growing culture of WM 06.482 expressing mCherry in the
absence of bacteria. ∗White arrows indicate fungal filaments that are being
colonized by the bacteria.
FIGURE 5 | The effect of gentamicin on P. aeruginosa (PASS01) and S. aurantiacum (WM 06.482) co-cultures growing in SCFM at 37◦C for 24 h.
Scale = 20 μm. (A) Co-culture of WM 06.482 and PASS01 without the antibiotic. (B) Active growth of S. aurantiacum in a co-culture treated with 8 mg/ml of
gentamicin to eradicate the bacterial growth.
involving S. aurantiacum and PASS2 strain (Supplementary
Figure S2).
Effect of Phenazines on the Growth of
S. aurantiacum
To test whether known virulence factors such as phenazines
secreted by P. aeruginosa were involved in the inhibition of
S. aurantiacum growth, the eﬀect of crude phenazine extracts
from P. aeruginosa strains PAO1, PASS1, and PASS2 were tested
on the two S. aurantiacum strains using a disk inhibition
assay. No inhibition was observed with disks saturated with the
crude extracts as seen in Figure 7. All S. aurantiacum strains
also showed resistance to a high concentration (10 mM) of
commercial phenazine pyocyanin. Phenazines are known to have
an inhibitory eﬀect against a wide range of fungal species (Kerr
et al., 1999).
Discussion
Most of the studies targeting bacterial-fungal interactions in vitro
have been performed with bacterial laboratory reference strains
using either fungus-speciﬁc culture media (PDA, SABD) and/or
minimal salts medium (Kerr et al., 1999; Hogan and Kolter, 2002;
McAlester et al., 2008; Bandara et al., 2010; Manavathu et al.,
2014). Diﬀerently to previous studies and to provide a better
focus, we used a CF sputum-mimicking medium, i.e., SCFM to
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FIGURE 6 | The inhibitory effect of P. aeruginosa on S. aurantiacum
during co-culture in SCFM, determined by the change in dry weight of
S. aurantiacum hyphae. A sterile polycarbonate membrane was used to
separate P. aeruginosa from S. aurantiacum in six well culture plates. Error
bars on each data point represent SEM of three independent experiments.
P-values were calculated by student’s t-test, where p < 0.05 was considered
significant.
explore the possible eﬀect of P. aeruginosa on S. aurantiacum
in the CF lung environment. We also used two recently isolated
clinical CF strains of P. aeruginosa, PASS1 and PASS2, together
with PAO1, a commonly used reference strain, and a clinical
S. aurantiacum isolate (WM 06.482) with a high established
virulence and a less-virulent type strain WM 08.202 to add to the
clinical relevance of the ﬁndings.
Our results demonstrated that P. aeruginosa strains exhibit
an inhibitory eﬀect against S. aurantiacum. Consistent with
the co-culture studies involving P. aeruginosa and other fungi,
initial screening using plate assays suggested that presence of
metabolically active (live) bacteria was necessary to inhibit the
growth of the fungus as heat killed cells had no eﬀect on
S. aurantiacum growth (Mowat et al., 2010). Further on, extracts
obtained from the bacterial monocultures failed to show any
inhibitory eﬀect. Thus it is possible that inhibition pathways
might involve genes that are expressed only in bacterial-fungal
co-cultures. In this respect our ﬁndings are similar to those of
Rella et al. (2012) who showed that the growth of C. neoformans
was not aﬀected by the cell extracts obtained from P. aeruginosa
strains PAO1 and PA14 cultured separately. The inhibition of
S. aurantiacum by cell lysates of P. aeruginosa may be explained
by the presence of bacterial exotoxins that are released during the
cell lysis.
Confocal microscopy has been used to study interactions
between chemically stained P. aeruginosa and major fungal lung
pathogens such as C. albicans and A. fumigatus in liquid co-
cultures (Bandara et al., 2010; Manavathu et al., 2014). However,
the use of chemical stains was limited by the cross staining of
bacteria and fungi thereby making it impossible to diﬀerentiate
between them under a confocal microscope (Bandara et al.,
2010). One of the key features of the current study is the use of
P. aeruginosa and S. aurantiacum strains that were genetically
tagged with ﬂuorescent proteins in order to characterize the
interactions in detail. To the best of our knowledge, this is the
ﬁrst report on successful genetic transformation of the newly
described S. aurantiacum species. As no homologous promoters
are available for this fungal species as yet, the ﬂuorescent marker
mCherry and the E. coli hph gene encoding hygromycin B
phosphotransferase were expressed under a heterologous pki
(pyruvate kinase) promoter derived from another ascomycetous
fungus, T. reesei (Te’o et al., 2002; Boon et al., 2008; Klix
et al., 2010). In previous studies, heterologous promoters
such as pki and gpdA have been successfully used for gene
expression across various phylogenetically close species (Punt
et al., 1990; Jieh-Juen Yu, 1998; Ruiz-Diez and Martinez-Suarez,
1999; Almeida et al., 2007). The amount of hygromycin B
required to inhibit the growth of S. aurantiacum was relatively
high (410 U/ml) compared to some other fungi, which shows
the highly resistant nature of S. aurantiacum also observed in
antifungal susceptibility tests described in other studies (Lackner
FIGURE 7 | Effect of P. aeruginosa phenazines on two S. aurantiacum isolates (A) WM 06.482 and (B) WM 08.202. Phenazines were extracted from
different P. aeruginosa strains (PAO1, PASS1, and PASS2) and redissolved in acetonitrile (ACN). LB medium extract, ACN solvent and commercial phenazine
(pyocyanin) were also tested against S. aurantiacum.
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et al., 2012). Although the transformation eﬃciency was low
(2.2 μg of plasmid DNA), transformant strains expressing the
mCherry protein were obtained.
Confocal microscopy of the bacterial-fungal co-cultures
revealed that bacteria elicit a speciﬁc inhibitory response by
establishing a physical contact with the fungal hyphae. Similar
types of interactions have also been observed in yeasts such as
C. albicans and ascomycetous fungi such as A. nidulans and
Alternaria alternata (Hogan and Kolter, 2002; Jarosz et al., 2011).
This association might be directed toward utilization of the
fungus by bacteria as an additional source of nutrients, or as an
additional matrix support to form bioﬁlms (Hibbing et al., 2010),
or it may be a strategy to promote their own survival by inhibiting
the fungal growth owing to nutrient limiting conditions in the
medium (Brand et al., 2008).
Under nutrient limiting conditions, bioﬁlm formation has
been described as an important characteristic for P. aeruginosa
mediated killing of other fungi such as C. albicans and
A. fumigatus (Hogan and Kolter, 2002; Manavathu et al., 2014).
Similarly, an inhibitory eﬀect was also displayed by the bioﬁlm
forming strains of P. aeruginosa (PASS1 and PAO1) against the
two S. aurantiacum strains in this study. PASS1 and PAO1 are
high virulence strains, which share many similarities in their
respective genomes. In contrast, the least virulent bacterial strain
PASS2 (Penesyan et al., under review) that failed to show an
eﬀect against the fungi lacks several virulence related genes
such as those encoding phenazines and the psl (polysaccharide
synthesis locus) gene cluster which is required for bioﬁlm
formation (Ma et al., 2009; Penesyan et al., under review).
The eﬀect of bacteria on the growth of the less virulent
S. aurantiacum strain WM 08.202 was much higher compared
to the more virulent WM 06.482 both in the plate assays
and in liquid co-cultures. This diﬀerence probably results from
their diﬀerent physiology as shown by Kaur et al. (2015)
and possibly higher resistance to antifungals of the more
virulent S. aurantiacum strain WM 06.482. These factors will
be studied further when annotated S. aurantiacum genomes are
available.
While bioﬁlm formation and colonization of fungal hyphae
in the nutrient limited SCFM liquid medium clearly contributed
to the inhibition of S. aurantiacum by P. aeruginosa, it was not
absolutely essential for the inhibitory eﬀect as the cross streak
assay with cultures not touching each other and disk inhibition
experiments using cell lysates also resulted in inhibition of fungal
growth. These indicated the possible involvement of secreted
diﬀusible bacterial exoproducts/metabolites in fungal growth
inhibition. One of these metabolites pyocyanin, a phenazine, is
an extracellular redox-active virulence factor which is widely
known to aﬀect the growth of a large number of fungal species
such as A. fumigatus, C. albicans, and C. neoformans (Kerr
et al., 1999; Laursen and Nielsen, 2004; Gibson et al., 2009).
Corroborating the highly resistant nature of S. aurantiacum,
the amount of commercial pyocyanin (i.e., 10 mM) included
in the test for comparison, was much higher than the MIC
(minimum inhibitory concentration) of pyocyanin used for
C. albicans and A. fumigatus (>0.3 mM; Kerr et al., 1999).
These amounts are signiﬁcantly higher than the amount of
pyocyanin normally detected in the lungs of CF patients (100μM;
Wilson et al., 1988). However, neither crude phenazines nor
pyocyanin showed an inhibitory eﬀect against S. aurantiacum
in our assays. A similar phenomenon has been observed
in some ascomycetous fungi such as A. sclerotiorum (Hill
and Johnson, 1969). Although it is not yet known if the
phenazines are modiﬁed or sequestered by S. aurantiacum, the
production of a red colored pigment in co-cultures could be
due to a detoxiﬁcation mechanism used by the fungus against
bacterial phenazines. However, further studies into the chemical
structure and UV and visible absorption spectra are required
in order to ascertain if the red pigment indicates a modiﬁed
phenazine.
In addition to phenazines, P. aeruginosa has also been reported
to produce a wide variety of other exoproducts/metabolites
such as proteases, elastases, haemolysin, and rhamnolipids that
contribute to bacterial virulence (McAlester et al., 2008; Ben Haj
Khalifa et al., 2011; Heeb et al., 2011; Rella et al., 2012; Mear
et al., 2013). Their possible activity against S. aurantiacum will
be worthy of a further study.
Most of the CF associated ﬁlamentous fungal species have
been isolated from the lungs of patients with prolonged antibiotic
therapies (Bakare et al., 2003). Previous clinical reports by Blyth
et al. (2010b) have also showed an increased prevalence of
S. aurantiacum in CF patients administered with antibacterial
drugs indicating that the presence of bacteria has an eﬀect on the
susceptibility of the lungs to fungal infection. In support of this
view, an increase in the growth of the fungus was observed upon
a decline in the bacterial growth through addition of gentamicin
to the co-culture medium in the present study. Therefore, it seems
that the P. aeruginosa strains prevalent in CF patients during
early stages of CF hinder fungal infection of lungs by inhibiting
their growth.
Conclusion
We have assessed the eﬀect of clinically relevant strains of
P. aeruginosa on a newly discovered fungal lung pathogen
S. aurantiacum in a synthetic lung-mimicking medium (SCFM)
that closely resembles the chemistry of CF sputum. An
inhibitory eﬀect of P. aeruginosa was observed on the
growth of S. aurantiacum, which can be mediated by the
production of biologically active metabolites. Bioﬁlm formation
and colonization of fungal hyphae by bacteria were also
important for S. aurantiacum growth inhibition. Surprisingly,
the toxic P. aeruginosa phenazine pigments, such as pyocyanin,
known to have an inhibitory eﬀect against other fungal species
including A. fumigatus and C. albicans, proved to be ineﬀective
against S. aurantiacum. This suggests involvement of other
virulence determinants and emphasizes the resilient nature
of S. aurantiacum compared to other fungi present in lung
infections. Further research may include transcriptomic studies
of P. aeruginosa – S. aurantiacum co-cultures in order to reveal
detailed molecular mechanisms underlying these interactions;
these studies will be facilitated by the upcoming annotated
S. aurantiacum genome.
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